Abstracts and papers

2013

Mullane KM, Winston DJ, Wertheim MS, Betts RF, Poretz DM, Camacho LH, Pergam SA, Mullane M, Stek JE, Sterling TM, Zhao Y, Manoff SB, Annunziato PW. Safety and Immunogenicity of Heat-Treated Zoster Vaccine (ZVHT) in Immunocompromised (IC) Adults. PubMed #23908479. J Infect Dis. 2013 Aug 1.

Bhogireddy V, Roston A, Chor J, Tilmon S, Mackevicius T, Keith LG, Patel A. Cervical Intraepithelial Neoplasia and Cancer in Women 35 Years and Older. PubMed #23760149, Journal of Lower Genital Tract Disease. 2013 Jun 11.

Patel UA, Lin AC. Flap outcomes when training residents in microvascular anastomosis in the head and neck. PubMed #23522660. American Journal of Otolaryngology 2013 Mar 19. pii: S0196-0709(13)00049-5. doi: 10.1016/j.amjoto.2013.02.005.

2012

Patel UA, Brennan TE. Disparities in head and neck cancer: assessing delay in treatment initiation. PubMed #22570084. Laryngoscope. 2012 Aug;122(8):1756-1760. doi: 10.1002/lary.23357. Epub 2012 May 8.

Paterson AH, Anderson SJ, Lembersky BC, Fehrenbacher L, Falkson CI, King KM, Weir LM, Brufsky AM, Dakhil S, Lad T, Baez-Diaz L, Gralow JR, Robidoux A, Perez EA, Zheng P, Geyer CE Jr, Swain SM, Costantino JP, Mamounas EP, Wolmark N. Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial. PubMed #22704583. Lancet Oncol. 2012 Jul;13(7):734-42. doi: 10.1016/S1470-2045(12)70226-7. Epub 2012 Jun 14.

Doll KM, Puliaev R, Chor J, Roston A, Patel UA, Patel A. Detection of gynecologic cancers in indigent women in an urban inner-city hospital. International Journal of Gynecologic Cancer. 2012;22(7):1113-7.

Patel A, Tilmon S, Bhogireddy V, Chor J, Patel D, Keith LG. Emergency Contraception after Sexual Assault: Changes from 2004 and 2009. J Reprod Med. 2012 Mar-Apr;57(3-4):98-104.

Scott-Ram R, Chor J, Bhogireddy V, Keith L, Patel A. Contraceptive choices of overweight and obese women in a publically funded hospital: possible clinical implications. Contraception. 2012;86(2):122-6.

Chor J, Goyal V, Roston A, Keith L, Patel A. Doulas as facilitators: the expanded role of doulas in abortion care. J Fam Plann Reprod Health Care. 2012;38(2):123-4.

Patel A, Schwarz EB. Cancer and contraception: Release date May 2012 SFP Guideline #20121. Contraception 2012;86:191-8.

2011

Patel UA, Howell KL. Local response to chemoradiotherapy for T4 laryngeal/hypopharyngeal carcinoma with cartilage invasion. Laryngoscope. 2011; 121 (1): 106-10.

Paydarfar JA, Patel UA. Submental flap versus radial forearm flap for oral cavity reconstruction: comparison of outcomes. Archives of Otolaryngology - Head and Neck Surgery. 2011; 137 (1): 82-87

2010

T. Aiti, K. Grauslyte, T. Mackevicius, E. A. Marcus, G. Lazzaro, J. Greager, T. E. Lad. Stage of breast cancer at presentation in non-U.S. citizens as compared to U.S. citizens. ASCO Annual Meeting 2010. Abstract No: 54540.

K. A. Dookeran, J. J. Dignam, K. Ferrer, M. Sekosan, E. K. Radeke, T. E. Lad, N. Holloway, W. J. McCaskill-Stevens, S. J. Gehlert. Race and the influence of p53 as a marker of prognosis in women of lower SES with breast cancer. ASCO Annual Meeting 2010. Abstract No: 50862.

S.B. Sreenivasappa B. Ciobanu, S. Sandhu, F. Feitosa, J. Samuel. Recurrence Pattern in early-stage breast cancer in a minority cohort. ASCO Annual Meeting 2010. Abstract No: 1600.

Paul G. Rubinstein, Tareq Braik, Shivi Jain, Jennifer Orsi, Shweta Gupta Gail Itokazu, Margaret Telfer, Muhamed Irfan, and Audrey French. Ritonavir Based Highly Active Retroviral Therapy (HAART) Correlates with Early Neurotoxicity When Combined with ABVD Treated HIV Associated Hodgkin Lymphoma but Not Non-Hodgkin Lymphoma. A Retrospective Study. ASH Annual Meeting 2010. Abstract No: 2807.

Tareq Alyousef, MD, Humar Hunnal Barta, MD Harsha Poola, MD, Namrata Das Batra, MD, Moushmi Shah, MD, Shweta Gupta, MD, Rose Catchatourian, MD. Phenomenon of A Normal Total Bilirubin with Increased Direct Bilirubin Noted in Patients with Plasma Cell Dyscrasias. Blood, ASH annual Meeting 2010.

Harsha V Poola, MD, Manila Gaddh, MD, Samuel N Ofori, MD, Moushmi Shah, MD, Mohammed A Kassem, MD, Augustin Haidau, MD, Rosalind Catchatourian, MD, Margaret Telfer, MD. A Three Year Experience at An inner City Safety-Net: Hospital with Immune Thrombocytopenic Purpura (ITP). Blood, ASH Annual Meeting 2010.

R.C. Hermann, C.B. Miller, R Catchatourian, D. Snyder, D. Williams, M Juna, J.E. Cortes. United States (US) practices for chronic myelogeneous: Leukemia (CML) management compared to other countries: A worldwide observational registry. J Clin Oncol 28:15s, 2010 (suppl: abstr 6585).

Barbara Yim, Anne Navaleza, Augustin Haidau, Shylendra Sreenivasappa, Mohammed Kassem, Bety C. Ciobanu, Tareq Braik, Manila Gaddh, Paul G Rubinstein, Moushmi Shah, Margaret Telfer, Rose Catchatourian. Single 4.5mg Dose of Rasburicase for Tumor Lysis Syndrome in Adults. Blood November, poster presentation at ASH Annual Meeting 2010.

A. Patel, A. Uy, E. K. Radeke, V. Barrera, H. A. Zaren. Oncocontraception in breast cancer care. ASCO Annual Meeting 2010. Abstract No: 54546.

T. Mackevicius, E. K. Radeke, T. E. Lad. Comprehensive Data management system for protocol patient and IRB documentation. ASCO Annual Meeting 2010. Abstract No: 54332.

Wong RK, James JL, Sagar S, Wyatt G, Nguyen-Tan PF, Singh AK, Lukaszczyk B, Cardinale F, Yeh AM, Berk L. RTOG 0537 Phase II/III Study Comparing Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) versus Pilocarpine in Treating Early Radiation-Induced Xerostomia (RIX): Phase II Results. ASTRO Abstract No: 2010-A-320.

Tareq Braik, Fred Rosen, Michael Mullane. Bevacizumab-associated bowel perforation after stent placement for metastatic rectal adenocarcinoma in a patient with ulcerative colitis. Community Oncology, December 2010.

2009

Patel UA, Patadia MO, Holloway N, Rosen F. Poor radiotherapy compliance predicts persistent regional disease in advanced head/neck cancer. Laryngoscope 2009; 119(3):528-33.

Cohen, E. E. W., Baru, J., Huo, D., Haraf, D. J., Crowley, M., Witt, M. E., Blair, E. A., Weichselbaum, R. R., Rosen, F., Vokes, E. E. and Stenson, K. Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy. 2009 Head Neck, 31: 1013–1021. doi: 10.1002/hed.21062.

2007

Dookeran KA, Wang Y, Gao X, Ferrer K, Sekosan M, Song S, Radeke EK, Khadire M, McCaskill-Stevens W, Zaren HA. Poverty predicts aggressive breast cancer phenotype and poor prognosis. ASCO - The Breast Cancer Symposium: Integrating Emerging Science into Clinical Practice, San Francisco, CA. Abstract No: 40436.

Dookeran KA, Wang Y, Gao X, Ferrer K, Sekosan M, De La Torre R, Radeke EK, McCaskill-Stevens W, Zaren HA. Absence of racial predilection for aggressive tumor phenotype among low social-economic status women with breast cancer. The 2007 Annual meeting of the American Society of Clinical Oncology, Chicago, IL. Abstract No: 10554.

Dookeran KA, Gao X, Wang Y, Ferrer K, Sekosan M, De La Torre R, Chang, WJ. Mohammed KM, Roman G, Lukaszczyk B, Radeke EK, McCaskill-Stevens W, Zaren HA. Basal subtype predicts poorer prognosis in younger, but not older, African-American women with breast cancer. The 98th annual meeting of the American Association for Cancer Research, Los Angeles, CA. Abstract No: 2510.

2006

Dookeran KA, Gao X, Wang Y, Lukaszczyk B, De La Torre R, Roman G, Ferrer K, Sekosan M, McCaskill-Stevens W, Zaren HA. p53 gene mutations in African-American women with breast cancer. Breast Cancer Research & Treatment 2006 (Submitted).

Dookeran KA, Gao X, Wang Y, Ferrer K, Sekosan M, Lukaszczyk B, Roman G, De La Torre R, Jacobson A, Radeke ER, Mackevicius T, Zaren HA, McCaskill-Stevens W. p53 status is more likely than basal subtype to predict survival in African-American women with breast cancer. Proc. AACR 2006 (In print).

Dookeran KA, Ferrer K, Sekosan M, Gao X, Wang Y, De La Torre R, Lukaszczyk B, Diaz de Leon L, Roman G, Zaren HA. p53 expression in breast cancer is more likely to predict survival in African-American than Hispanic or white women. J. Clin. Oncol. Proc. ASCO 2006;24:#10001.

Dookeran KA, Ferrer K, Sekosan M, Gao X, Wang Y, Diaz de Leon L, Lukaszczyk B, De La Torre R, Roman G, Radeke ER, Muthyala N, Rogowski WA, Zaren HA. Underserved African-American & white women with breast cancer have similar prognostic profiles for estrogen receptor and tumor grade. Proc. AACR 2006;47:#3696.

2005

Dookeran KA, Ferrer K, Sekosan M, Gao X, Sciupokiene E, Wang Y, De La Torre R, Diaz de Leon L, Lukaszczyk B, Zhang S, Song S, Zaren HA. HER2/neu overexpression and survival in African-American women with breast cancer. Proc. AACR 2005;46:114-15,#489.

Dookeran KA, Ferrer K, Sekosan M, Sciupokiene E, Gao X, Wang Y, Lukaszczyk B, Diaz de Leon L, De La Torre R, Zaren HA. p53 expression predicts poorer survival in African-American women with breast cancer. Proc. ASCO 2005;23:870s,#9635.

Dookeran KA, Wang Y, Ferrer K, Sekosan M, Gao X, De La Torre R, Diaz de Leon L, Lukaszczyk B, Roman G, Muthyala N, Rogowski WA, Zaren HA. Low socio-economic status African-American, Hispanic White women with breast cancer demonstrate similar hormone receptor status, tumor grade survival. Breast Cancer Research & Treatment 2005 (In print) 2005;94:S156.

Dookeran KA, Sciupokiene E, Wang Y, Lin J, Mackeviciute-Naujokas A, Whitehall M, Muthyala N, Rogowski WA, Zaren HA. Health attitudes, beliefs and habits affect breast cancer screening practice among minority-underserved and low income women. Proc. AACR 2005;759,#3227.

2004

Dookeran KA, Sciupokiene E, Mackeviciute-Naujokas A, Wang Y, Lin JM, Ferrer K, Sekosan M, Zhang S, Gao X, Zaren HA. Improved yield of perioperative screening for metastases in African-American women with operable breast cancer. Breast Cancer Research & Treatment 2004;88:S97.

Dookeran KA, Sciupokiene E, Mackeviciute-Naujokas A, Elfarra G, Wang Y, Rogowski WA, Muthyala N, Caluser C, Gao X, Ferrer K, Sekosan M, Zaren HA. Poor Quality Reporting of Screening Mammography is Associated with Lower Rates of Diagnosis of Early-Stage Breast Cancer in Minority-Underserved Women. Proc. AACR 2004;45:1213,#5260.

Dookeran KA, Sciupokiene E, Mackeviciute-Naujokas A, Ferrer K, Sekosan M, Gao X, De La Torre R, Diaz de Leon L, Lukaszczyk B, Elfarra G, Wang Y, Rogowski WA, Muthyala N, Caluser C, Zaren HA. Early Stage Interval Breast Cancers in African-American Women Demonstrate ER Negative Status & More Aggressive Tumor Biology. Proc. AACR 2004;45:1213,#5259.

Dookeran KA, Sciupokiene E, Ferrer K, Sekosan M, Mackeviciute-Naujokas A, Gao X, Elfarra G, Wang Y, Rogowski WA, Muthyala N, Zaren HA. HER2/neu Status in African-American Women with Breast Cancer. Proc. AACR 2004;45:1213,#5261.

Dookeran KA, Gao X, Ferrer K, Sciupokiene E, De La Torre R, Diaz de Leon L, Lukaszczyk B, Zhang S, Sekosan M, Zaren HA. Tumor biology in African-American women with breast cancer treated with preoperative chemotherapy: lack of pathologic complete response is related to p53 overexpression. Proc. ASCO 2004;23:95,#880.

Zaren HA, Sciupokiene E, Mackeviciute-Naujokas A, Gao X, Ferrer K, Wang Y, Zhang S, Sekosan M, Dookeran KA. African-American women with breast cancer treated with preoperative chemotherapy have reduced pathologic complete response rates. Proc. ASCO 2004;23:94,#876.

Dookeran KA, Ferrer K, Sekosan M, Gao X, De La Torre R, Diaz de Leon L, Lukaszczyk B, Zhang S, Naujokas A, Sciupokiene E, Zaren HA. Analysis of hormone receptor function in African-American women with breast cancer. Breast Cancer Research & Treatment 2004; 88:S98.

2003

Dookeran KA, Gao X, Ferrer K, Sekosan M, Yang J, Sciupokiene E, Mackeviciute-Naujokas A, Rogowski WA, Muthyala N, Zaren HA. The Significance of p53 Immunoreactivity in African-American Patients with Breast Cancer. Eur. J. Surg. Oncol. 2003;29:829-30.

Dookeran KA, Sciupokiene E, Mackeviciute-Naujokas A, Elfarra G, Rogowski WA, Patel J, Ruestow P, Zaren HA. Minority-Underserved Women Treated for Breast Cancer Are at Increased Risk for Poor Mental Health Outcomes. Proc. AACR 2003:44;185.

Dookeran KA, Gao X, Ferrer K, Sekosan M, Kumar B, Yang J, Sciupokiene E, Mackeviciute-Naujokas A, Rogowski WA, Catchatourian R, Zaren HA. Evaluation of p53 Immunoreactivity in African-American Patients with Breast Cancer. Proc. AACR 2003:44;295.

Dookeran KA, Sciupokiene E, Mackeviciute-Naujokas A, Rogowski WA, Elfarra G, Patel J, Ruestow P, Lavelle MB, Caluser C, Kumar B, Gao X, Yang J, Ferrer K, Sekosan M, Catchatourian R, Zaren HA. Lower Rates of Diagnosis of Early-Stage Breast Cancer in Minority-Underserved Patients is Associated with Inadequate Screening Practice. Proc. AACR 2003 44;295.

Sciupokiene E, Koko I, Dookeran KA, Mackeviciute-Naujokas A, Rogowski WA, Yim B, Catchatourian R, Zaren HA. Factors influencing non-compliance with systemic chemotherapeutic regimens for breast cancer among minority-underserved women. ASCO 2003:22;90.

Zaren HA, Sciupokiene E, Mackeviciute-Naujokas A, Rogowski WA, Elfarra G, Muthyala N, Patel J, Carter M, Ubaka J, Dookeran KA. Recruitment & Retention of Minority-Underserved Participants to the Star/P2 Study is Difficult. ASCO 2003:22;94.

Dookeran KA, Gao X, Ferrer K, Sekosan M, Yang J, Kumar B, Sciupokiene E, Mackeviciute-Naujokas A, Rogowski WA, Zaren HA. HER-2/neu & EGFR Status in African-American Patients with Breast Cancer. Proc. ASCO 2003:22;904.

Zaren HA, Sciupokiene E, Mackeviciute-Naujokas A, Ferrer K, Sekosan M, Caluser C, Koko I, Petrosyan M, Pei K, Muthyala N, Rogowski WA, Dookeran KA. Outcome Disparity for Preoperative or Neoadjuvant Chemotherapy in African-American Breast Cancer Patients. AACR Conference: Advances in Breast Cancer Research Proceedings 2003:B40.

Dookeran KA, Gao X, Ferrer K, Sekosan M, Sciupokiene E, Mackeviciute-Naujokas A, Muthyala N, Rogowski WA, Zaren HA. p53 Immunostaining in African-American Breast Cancer Patients is Significantly Associated with Higher Stage & Negative Hormone Receptor Status. AACR Conference: Advances in Breast Cancer Research Proceedings 2003:A12.

Dookeran KA, Gao X, Yang J, Ferrer K, Sekosan M, Sciupokiene E, Mackeviciute-Naujokas A, Zaren HA. ER beta expression parallels ER alpha/ PR expression and is inversely related to EGFR expression in African American women with breast cancer. Breast Cancer Research & Treatment 2003;82:S63.

Dookeran KA, Gao X, Yang J, Ferrer K, Sekosan M, Sciupokiene E, Mackeviciute-Naujokas A, Rogowski WA, Muthyala N, Koko I, Zaren HA. Technical differences contribute to hormone receptor negative status in African-American underserved patients. Breast Cancer Research & Treatment 2003 (In print) 2003;82:S61-2.

2002

Dookeran KA, Sciupokiene E, Yang J, Elfarra G, Rogowski W, Tran H, Catchatourian R, Zaren HA. Factors influencing postmastectomy breast reconstruction among minority-underserved patients. The Breast 2002; (In publication).

Dookeran KA, Sciupokiene E, Esmailzadeh H, Frush T, Shin F, Rogowski W, Tran H, Yang J, McFarlin M, Reed A, Sekosan M, Catchatourian R, Zaren HA. Comparison of prognostic factors for minority-underserved patients with breast cancer. Proc. AACR 2002;43:238.

Dookeran KA, Sciupokiene E, Esmailzadeh H, Frush T, Shin F, Tran H, Rogowski W, Yang J, Reed A, McFarlin M, Sekosan M, Catchatourian R, Zaren HA. Outcomes for breast cancer screening & early detection in minority-underserved women. Proc. AACR 2002;43:238.

Dookeran KA, Sciupokiene E, Esmailzadeh H, Frush T, Tran H, Rogowski W, Yang J, Sekosan M, Catchatourian R, Zaren HA. Analysis of results for breast cancer screening & early detection in minority-underserved American women. Eur. J. Surg. Oncol. 2002;28:329.

Dookeran KA, Sciupokiene E, Esmailzadeh H, Frush T, Rogowski W, Tran H, Yang J, Sekosan M, Catchatourian R, Zaren HA. A comparison of prognostic factors for minority-underserved American patients with breast cancer. Eur. J. Surg. Oncol. 2002;28:334-5.

Yang J, Dookeran KA, Sekosan M, Sciupokiene E, Rogowski W, Tran H, Catchatourian R, Zaren HA. African-American women with breast cancer are more likely to be ER-beta positive. Proc. ASCO 2002;21:289b.

Dookeran KA, Sciupokiene E, Frush T, Esmailzadeh H, Shin F, Rogowski W, Tran H, Yang J, Sekosan M, Catchatourian R, Zaren HA. HER-2/neu overexpression in African-American women with breast cancer is not associated with negative ER status or higher stage disease. Proc. ASCO 2002;21:296b.

Zaren HA, Sciupokiene E, Frush T, Esmailzadeh H, Shin F, Rogowski W, Tran H, Yang J, Sekosan M, Catchatourian R, Dookeran KA. Minority-underserved women with breast cancer do not receive worse treatment on NCI studies. Proc. ASCO 2002;21:45b.

Dookeran KA, Yang J, Sekosan M, Sciupokiene E, Rogowski W, Tran H, Catchatourian R, Zaren HA. Black women with breast cancer are more likely to be ER-beta positive. British Journal of Cancer 2002;86:S39.

Dookeran KA, Sciupokiene E, Frush T, Esmailzadeh H, Shin F, Rogowski W, Tran H, Yang J, Sekosan M, Catchatourian R, Zaren HA. Her-2/Neu overexpression in Black women with breast cancer is not associated with negative ER status or higher stage disease. British Journal of Cancer 2002;86:S39.

Dookeran KA, Sciupokiene E, Rogowski WA, Elfarrar G, Caluser C, Yang J, Sekosan M, Catchatourian R, Zaren HA. Fine needle aspirate biopsies of breast lesions are more commonly unsatisfactory and inaccurate when performed by non-surgeons. Breast Cancer Research & Treatment 2002;76:S39.

2001

Dookeran KA, Rossi H, Shin F, Tran H, Mullai N, Samuel J, Catchetorian R, Zaren HA. Prognostic differences for African-American and other medically-underserved patients with breast cancer. Proc. AACR 2001;42:890.

Babu L, Agbemadzo B, Mullai N, Samuel J, Dissanayake R, Kio E, Subramaniam D, Dookeran KA, Zaren HA. Incidence of breast cancer in patients less than 40 years old in a minority-based urban hospital. Proc. ASCO 2001;20:36b.

Samuel J, Mullai N, Dissanayake R, Agbemadzo B, Kio E, Subramaniam D, Dookeran KA, Zaren HA. Demographics of breast cancer in a minority-based institution. Proc. ASCO 2001;20:323b.

Dissanayake R, Mullai N, Samuel J, Agbemadzo B, Kio E, Subramaniam D, Dookeran KA, Zaren HA, Ramadurai J. Correlation of estrogen receptor (ER) and HER2/neu (HER2) overexpression in breast cancer patients. Proc. ASCO 2001;20:328b.

Mullai N, Samuel J, Dissanayake R, Agbemadzo B, Subramaniam D, Kio E, Dookeran KA, Zaren HA. Discordance in prognostic factor analysis in breast core biopsies vs. surgical specimens. Proc. ASCO 2001;20:338b.

Dookeran KA, Rossi H, Tran H, Shin F, Catchetourian R, Samuel J, Mullai N, Zaren HA. Differences in breast cancer management outcomes for African-American and other medically-underserved patients. Proc. ASCO 2001;20:216b.

2000

Dookeran KA. Mechanisms of antitumor activity for sustained-release nitric-oxide donor, Nitroprusside in Ethiodol. Proc. AACR 2000;41:280.